Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Completed 23Unknown 9Terminated 6Recruiting 5Withdrawn 4Not yet recruiting 4

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4Genitourinary 1Dermatologic 1

Conditions

Carcinoma, Hepatocellular 2Pancreatic Adenocarcinoma Resectable 1Cholangiocarcinoma 1Bile Duct Neoplasms 1

Interventions

Fluorouracil 51Oxaliplatin 49Gemcitabine 47Leucovorin 41Capecitabine 35Bevacizumab 29Irinotecan 25Cisplatin 22Radiotherapy 18Radiosurgery 18pembrolizumab 16Nivolumab 16Cetuximab 15Taxes 14Sorafenib 14Paclitaxel 13Biopsy 13Surgical Procedures, Operative 12Drug Therapy 11atezolizumab 10Radiation 10Albumin-Bound Paclitaxel 10lenvatinib 9durvalumab 9Magnetic Resonance Spectroscopy 9Folfox protocol 9Cyclophosphamide 9130-nm albumin-bound paclitaxel 9spartalizumab 8Chemotherapy, Adjuvant 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × Electroporation × Gastrointestinal × Clear all
NCT04717687 2022-07-13

HOPE

Poitiers University Hospital

Phase NA Withdrawn
Gastrointestinal

Cholangiocarcinoma

NCT03337997 2021-05-06

A Pilot Study of IRE for Resectable Pancreatic Cancer

University of Saskatchewan

Phase NA Withdrawn
Gastrointestinal

Pancreatic Adenocarcinoma Resectable

NCT04404647 2021-03-26

Irreversible Electroporation of Unresectable Liver Tumors

Aalborg University Hospital

Phase NA Withdrawn
Gastrointestinal

Bile Duct Neoplasms, Carcinoma, Hepatocellular

NCT03040453 2020-11-30

IRAL

Karolinska Institutet

Phase NA Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡